Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 study evaluating nab-paclitaxel and gemcitabine with or without VCN-01 in metastatic pancreatic cancer; the trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• VCN-01

Snippet

Sponsor: Theriva Biologics SL | Conditions: Pancreatic Adenocarcinoma, Metastatic | Phase 2 | Status: COMPLETED